UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K/A
(Amendment No. 5)
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)   April 20, 2016


NVE Corporation

(Exact name of registrant as specified in its charter)

 

Minnesota

000-12196

41-1424202

(State or other jurisdiction of incorporation)

(Commission File Number)
(IRS Employer Identification No.)


11409 Valley View Road, Eden Prairie, Minnesota

55344

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code (952) 829-9217

                                                                                                                                
(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
Explanatory Note
     This Amendment No. 5 to Form 8-K is being filed to disclose a fifth amendment to our Supplier Partnering Agreement dated January 3, 2006, as amended by Amendment No. 1 to the Agreement dated September 6, 2007, Amendment No. 2 dated December 15, 2009, Amendment No. 3 dated September 13, 2010, and Amendment No. 4 dated February 1, 2011, by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division (“St. Jude”), and us.


Item 1.01. Entry into a Material Definitive Agreement.

General Information
     We supply products to St. Jude under the Supplier Partnering Agreement as amended.

Description of the Terms of the Amendment
     Effective as of April 20, 2016 we executed Amendment No. 5 to the Agreement. Amendment No. 5 extends the Agreement term through January 1, 2021, requires us to comply with certain laws and regulations, and adds other obligations for us. The Amendment is filed as Exhibit 10.7 to this Current Report on Form 8-K/A.

     The foregoing description of the Supplier Partnering Agreement as amended does not purport to be complete and is qualified in its entirety by reference to the full text of Amendment No. 5 filed as Exhibit 10.7, and the documents incorporated by reference as Exhibits 10.1, 10.2, 10.3, 10.4, 10.5, and 10.6 to this Current Report Amendment No. 5 to Form 8-K/A and incorporated by reference into this Item 1.01.

 

 

2

 
SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date   April 21, 2016 NVE CORPORATION
(Registrant)
 
/s/ CURT A. REYNDERS
Curt A. Reynders
Chief Financial Officer

 

 

 

3


 
INDEX TO EXHIBITS

 
Exhibit #
Description
 
  10.1 Indemnification Agreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporated by reference to the Form 8-K filed September 27, 2005).
 
  10.2+ Supplier Partnering Agreement by and between St. Jude and the company (incorporated by reference to the Form 8-K filed January 4, 2006).
 
  10.3+ Amendment No. 1 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed September 10, 2007).
 
  10.4+ Amendment No. 2 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed December 18, 2009).
 
  10.5+ Amendment No. 3 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed September 16, 2010).
 
  10.6 Amendment No. 4 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed February 7, 2011).
 
  10.7 Amendment No. 5 to Supplier Partnering Agreement between Pacesetter, Inc. and the company (filed with this Current Report on Form 8-K/A).
 
+Confidential portions of this exhibit were deleted and filed separately with the SEC under a request for confidential treatment pursuant to Rule 24b-2 or Rule 406.








4

NVE and Pacesetter Confidential
 
Amendment No. 5 to Supplier Partnering Agreement

This Amendment No. 5 (“Amendment No. 5”) to Supplier Partnering Agreement dated January 1, 2006 (as previously amended, the “Agreement”) by and between Pacesetter, Inc., 15900 Valley View Court, Sylmar, California 91342-3577 (“Buyer”), and NVE Corporation, 11409 Valley View Road, Eden Prairie, MN  55344-3617 (“Seller”), is executed by and between Buyer and Seller. Buyer and Seller hereby agree to amend the Agreement as follows:
 
1. Section 1, Term of Agreement , is hereby deleted and replaced with the following: 
 
  1. Term of Agreement . This Agreement begins on January 1, 2006, and will remain in force through January 1, 2021, unless terminated earlier.  
 
2. The following is hereby added to the end of Section 2, Purchase orders , of the Agreement, as follows:
 
  Except as set forth below in this Section 2, Buyer’s responsibility for purchases under this Agreement is limited to purchase orders placed by Buyer. In the event that termination of the Agreement is by Buyer pursuant to Section 11.1, then Buyer shall (at its sole option) either (i) purchase from Seller all actual Seller inventory up to the required Seller inventory levels and all work-in-progress and material created or purchased due to Buyer’s inventory requirements within 180 days of such termination; or (ii) purchase the actual Seller inventory and require that Seller process to completion (and then purchase the completed inventory from Seller) additional inventory up to the required Seller inventory amounts established pursuant to Attachment 1 of Agreement. Except as otherwise expressly provided in this Agreement, Buyer shall have no liability or responsibility for the cost of any actual Seller inventory or other materials or labor incurred by or on behalf of Seller prior to, during, or after the term of this Agreement.
 
3. Prices shall be negotiated in good faith effective January 1 each calendar year in the amended term of this Agreement. Section 6.2 of the Agreement is hereby amended so that the price adjustment provision contained in the third bullet of Section 6.2 applies to each year during the term of this Agreement as amended.
 
4. The following new Section 10, Inspections / Compliance with Law, and Section 11, Termination, are hereby added to the Agreement as follows, with the remaining Section 10 of the Agreement renumbered accordingly including any references thereto:
 
  10. Inspections / Compliance with Law .
 
    10.1
During the Term, Buyer and any affiliate of Buyer shall have the right, during normal business hours and upon
 
Confidential 1 4/15/2016

NVE and Pacesetter Confidential
 
    reasonable prior notice, to have employees or representatives conduct compliance inspections or other inspections, audits and investigations to ensure that Seller’s handling, production, testing, storage and shipping of product complies with all applicable Laws including, without limitation, QSR; provided, however, that such inspection, audit or investigation shall not unreasonably interfere with the operations at the production facility. Seller shall cooperate in any such inspection, audit or investigation conducted by Buyer, any of its affiliates or designees.
 
10.2 Further, upon reasonable prior notice to Seller, Buyer shall also have the right to: (i) observe and inspect Seller’s manufacture of the product and the manner in which Seller conducts quality control of the products, (ii) inspect Seller’s plant and records relating to Seller’s quality and other controls related to its manufacture of the product, and (iii) review all batch reports, device history files and related documents. Seller shall make such books and records available to Buyer and permit Buyer to make extracts from or copies of such books and records for such purposes.
 
10.3 Seller shall notify Buyer immediately upon receipt of any notice of inspection by any Governmental Authority related to any aspect of the manufacture of the product and shall provide Buyer with a copy of the results of any such inspection or observation (whether oral or written) promptly after Seller’s receipt thereof. In addition, Buyer shall have the right to have a representative present at any such portion of the inspection involving the product.
 
10.4 Seller shall, in performing its obligations under this Agreement, comply with all applicable existing and future laws, regulations, and acts of any applicable government, including the United States, (“Laws”) and with the highest ethical standards of business conduct, including without limitation the United States Foreign Corrupt Practices Act of 1977 as amended and the Anti-Boycott Laws, including without limitation the Export Administration Act and the Ribicoff Amendment to the 1976 Tax Reform Act (TRA) as well as applicable country of origin marking requirements under applicable Laws. Further, Seller shall take no action on behalf of Buyer, which would cause Buyer to be in violation of applicable Laws. Specifically, Seller agrees not to make, directly or indirectly, any offer,
 
Confidential 2 4/15/2016

NVE and Pacesetter Confidential
 
    payment, promise to pay or authorization of the payment of any money, gift or other thing of value to any person who is an official, agent, employee or representative of any government, including the United States or any ministry, agency, office, department or other instrumentality thereof that is a customer of Seller or Buyer, or of any private customer, or to any other person while knowing or having reason to believe that all or any portion of such money, gift or thing of value would or will be offered, given or promised, directly or indirectly, to any such official, agent, employee, representative or private customer in violation of the laws, regulations and acts described in this Section. Upon request, or should Buyer ever become the subject of an audit or investigation by a US, European or other governmental authority, including under any anti-boycott regulations, anti-bribery legislation, or related export legislation, the Seller agrees to cooperate fully with Buyer in connection with such investigation and to provide such information and records to Buyer with respect to Seller’s activities under this Agreement as may be reasonably requested by Buyer.
 
10.5 Seller continuously monitors the materials it uses in the manufacturing process and manufacturing process controls for compliance with the European Union Registration, Evaluation, Authorization and Restriction of Chemical Substances (Directive 2006/1907/EC) (“REACh”), and shall provide (at no cost) a declaration that states Seller is REACh compliant to Buyer upon written request. Seller certifies that the materials incorporated into the Component(s): (i) comply with the laws regarding slavery and human trafficking of the country or countries in which it does business and that it is also in compliance with all applicable laws (including but not limited to California Civil Code Section 1714.43) and (ii) do not contain any “conflict minerals” originating from the Democratic Republic of the Congo or an adjoining country as more fully set forth in Section 1502 (et seq.) of the Dodd-Frank Act and corresponding regulations (collectively, the “Dodd-Frank Act”). Seller further agrees to provide (at no cost) an appropriate declaration and information to Buyer upon written request in order to assist Buyer with reporting and compliance pursuant to the Dodd-Frank Act.
 
10.6 Buyer hereby incorporates by reference any Federal Acquisition Regulations (FAR) clauses at 48 CFR Part 52
 
Confidential 3 4/15/2016

NVE and Pacesetter Confidential
 
      that are in effect as of the date of this Agreement as well as any Defense Federal Acquisition Regulations (DFARS) clauses at 48 CFR Part 252, as applicable, including the clauses required to be flowed down pursuant to FAR 52.212-5(e)(1) and FAR 52.244-6. Seller also represents and warrants that it complies with all regulations relating to Small Business Subcontracting, including FAR 52.219-8.
 
  10.7 Buyer is an equal opportunity employer and federal contractor or subcontractor. Consequently, the parties agree that, as applicable, they will abide by the requirements of 41 CFR 60-1.4(a), 41 CFR 60-300.5(a) and 41 CFR 60-741.5(a) and that these laws are incorporated herein by reference. These regulations prohibit discrimination against qualified individuals based on their status as protected veterans or individuals with disabilities, and prohibit discrimination against all individuals based on their race, color, creed, religion, sex, national origin, marital status, age, citizenship, sexual orientation, gender identity and/or gender expression or status with respect to public assistance. These regulations require that covered prime contractors and subcontractors take affirmative action to employ and advance in employment individuals without regard to race, color, creed, religion, sex, national origin, marital status, age, citizenship, sexual orientation, gender identity and/or gender expression or status with respect to public assistance, protected veteran or disability status. The parties also agree that, as applicable, they will abide by the requirements of Executive Order 13496 (29 CFR Part 471, Appendix A to Subpart A), relating to the notice of employee rights under federal labor laws.
 
11. Termination .
 
  11.1 Buyer may terminate this Agreement at any time upon sixty (60) days’ prior written notice to Seller.
 
  11.2 This Agreement may be terminated by either party if:
 
    (a) the other party is in material breach of any material term or obligation of this Agreement and such material breach is not cured within thirty (30) days after receipt of written notice of such material breach from the terminating party; or
 
Confidential 4 4/15/2016

NVE and Pacesetter Confidential
 
  (b) the other party is adjudicated insolvent, has a receiver of its assets or property appointed, or files or has filed against it a petition in bankruptcy and such breach is not cured within thirty (30) days of such event; or
 
(c) the other party ceases or threatens to cease to carry on all or any substantial part of its business that is relevant to this Agreement.
 
11.3 The parties’ obligations pursuant to Sections 2, 6, and 8-12 shall survive termination or expiration of this Agreement.
 
11.4 Any termination shall be without prejudice to any other right or remedy afforded to either party under this Agreement and will not affect any rights or obligations, which have arisen prior to the date of such termination.
 
5. The product proprietary technology placed in escrow by Seller pursuant to Attachment 4 of the Escrow Agreement is hereby deleted in its entirety and superseded and replaced by new Attachment 4 attached to this Amendment No. 5 as Exhibit A and incorporated by reference to the Agreement.
 
6. Additional product proprietary technology will be placed in escrow by Seller pursuant to Section 10.10 of the Agreement within 120 days of execution of this Amendment No. 5 and shall include the materials identified in new Attachment 5 to the Escrow Agreement attached to this Amendment No. 5 as Exhibit B and incorporated by reference to the Agreement. The parties agree to cooperate to update the Escrow Agreement to incorporate the revisions and additions set forth in Attachments 4 and 5 within 120 days of the execution of this Amendment No. 5.
 
7. Except as expressly amended above, all other terms and conditions of the Agreement as amended will continue in full force and effect without change or modification.
 
Confidential 5 4/15/2016

NVE and Pacesetter Confidential
 
IN WITNESS OF THIS AGREEMENT, the parties have signed below by their authorized officers, effective as of the later date below:
 
PACESETTER, INC. NVE CORPORATION
 
 
By:    /s/ CARL CADWALLADER  By:   /s/ DANIEL A. BAKER 
       Carl Cadwallader
      Vice President
      Process Development and Infrastructure

Date:   4/20/16 
       Daniel A. Baker
      President & CEO
 
 
Date:   4/18/16 
 
 
 
 
 
Confidential 6 4/15/2016

NVE and Pacesetter Confidential
 
Exhibit A
 
(ATTACHMENT 4)
 
Document Number   Document Title Notes:                    
1 Key Equipment Needed to Build St. Jude Die
 
2 Multilayer Blank Wafer Process - Materials Checklist  
3 NVE Specification 12003
4 NVE Specification 12081
5 NVE Specification 12086
6 NVE Specification 12084
7 NVE Specification 12082
8 NVE Specification 12092
9 NVE Specification 12088
10 NVE Specification 12068
11 NVE Specification 12065
12 NVE Specification 12085
13 NVE Specification 12051
14 NVE Specification 12053
15 NVE Specification 12052
16 NVE Specification 12055
17 NVE Specification 12054
18 NVE Specification 12039
19 NVE Specification 12042
20 NVE Specification 12073
21 NVE Specification 12043
22 NVE Specification 12044
23 NVE Specification 12059
24 NVE Specification 12049
25 NVE Specification 12058
26 NVE Specification 12057
27 NVE Specification 12062
28 NVE Specification 12061
29 NVE Specification 12063
30 NVE Specification 12066
31 NVE Specification 12218
32 NVE Specification 12275
33 NVE Specification 12298
34 Runcard 8001
35 Runcard 8011_E
36 NVE Specification 10311
37 NVE Specification 6201
38 NVE Specification 06311
39 Note on Letters of Authorization
40 NVE SpecificationCS.BA010_K Updated May 2015; will be
updated in May 2016 with
BA012 Information
41 NVE Specification SN09001_M Updated May 2015
42 NVE Specification SN09003_C Updated May 2015
43 NVE SpecificationSN2008_B Updated May 2015
44 NVE Specification SN02007_B Updated May 2015
45 NVE Specification SN2006_B Updated May 2015
46 NVE Specification SN02109_A Updated May 2015
47 NVE Specification SN2002_J Updated May 2015
48 NVE Specification 01108_C Updated May 2015
49 NVE Specification SN 06311_B Updated May 2015
50 NVE Specification 2108_A Updated May 2015
51 NVE Specification SN02107_A Updated May 2015
52 NVE Specification 1004A Updated May 2015
53 NVE Specification SN02003E Updated May 2015
54 NVE Specification SN05013_A Updated May 2015
 
 
 
Confidential 7 4/15/2016

NVE and Pacesetter Confidential
 
Exhibit B

(ATTACHMENT 5)

NVE Specification QA-00-055 To be added in May 2016   
NVE Specification QA-00-054 To be added in May 2016

 
 
 
 
Confidential 8 4/15/2016